These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1212356)

  • 1. Proceedings: Therapy of methyl cholanthrene induced CBA mouse tumours with Corynebacterium parvum and irradiated tumour cells.
    Bomford R
    Br J Cancer; 1975 Aug; 32(2):241. PubMed ID: 1212356
    [No Abstract]   [Full Text] [Related]  

  • 2. Active specific immunotherapy of mouse methylcholanthrene induced tumours with Corynebacterium parvum and irradiated tumour cells.
    Bomford R
    Br J Cancer; 1975 Nov; 32(5):551-7. PubMed ID: 1082344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proceedings: Treatment of a metastasizing murine tumour with Corynebacterium parvum.
    Sadler TE; Castro JE
    Br J Cancer; 1975 Feb; 31(2):264. PubMed ID: 1164486
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhancement of concomitant immunity after radiation therapy and immunotherapy in a syngeneic murine tumour system.
    Deneufbourg JM
    Acta Radiol Oncol; 1982; 21(5):345-8. PubMed ID: 6297254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings: The effect of Corynebacterium parvum on a subcutaneous tumour.
    Jones PD; Sadler TE; Castro JE
    Br J Surg; 1976 Aug; 63(8):659-60. PubMed ID: 953487
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of Corynebacterium parvum on tumour metastases in mice.
    Castro JE
    Br J Surg; 1977 Oct; 64(10):721-4. PubMed ID: 922293
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of C. parvum on growth and induction of intracerebral tumours in mice.
    Osborn DE; Sadler TE; Castro JE
    Br J Cancer; 1977 Apr; 35(4):420-5. PubMed ID: 857825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of Corynebacterium parvum presensitization to modify the antitumor effects of systemic and local therapeutic injections of C. parvum in mice.
    Scott MT
    J Natl Cancer Inst; 1976 Mar; 56(3):675-7. PubMed ID: 815560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies with a spontaneous mouse tumor. I. Growth in normal mice and response to Corynebacterium parvum.
    Woodruff MF; Whitehead VL; Speedy G
    Br J Cancer; 1978 Mar; 37(3):345-55. PubMed ID: 638014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further observations on the effect of C. parvum and anti-tumour globulin on syngeneically transplanted mouse tumours.
    Woodruff MF; Inchley MP; Dunbar N
    Br J Cancer; 1972 Apr; 26(2):67-76. PubMed ID: 5038327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological effects of Corynebacterium parvum. 3. Amplification of resistance and impairment of active immunity to murine tumours.
    Smith SE; Scott MT
    Br J Cancer; 1972 Oct; 26(5):361-7. PubMed ID: 4343677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corynebacterium parvum as a therapeutic antitumor agent in mice. II. Local injection.
    Scott MT
    J Natl Cancer Inst; 1974 Sep; 53(3):861-5. PubMed ID: 4213016
    [No Abstract]   [Full Text] [Related]  

  • 13. Organ distribution of technetium-99m-labeled corynebacterium parvum in normal and tumor-bearing mice.
    Barth RF; Singla O
    Cancer Res; 1978 Jan; 38(1):32-4. PubMed ID: 618580
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of transplanted methylcholanthrene induced fibrosarcomata and Corynebacterium parvum on the immune response of CBA and A-HeJ mice to thymus dependent and independent antigens.
    James K; Ghaffar A; Milne I
    Br J Cancer; 1974 Jan; 29(1):11-20. PubMed ID: 4820942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgery plus Corynebacterium parvum immunotherapy for Lewis lung carcinoma in mice.
    Karrer K; Rella W; Goldin A
    Eur J Cancer (1965); 1979 Jun; 15(6):867-73. PubMed ID: 499275
    [No Abstract]   [Full Text] [Related]  

  • 16. Corynebacterium parvum as a therapeutic antitumor agent in mice. I. Systemic effects from intravenous injection.
    Scott MT
    J Natl Cancer Inst; 1974 Sep; 53(3):855-60. PubMed ID: 4213015
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunomodulation of chemically induced fibrosarcoma by Corynebacterium parvum.
    Gupta N; Sehgal S; Aikat BK
    Indian J Med Res; 1980 Nov; 72():688-95. PubMed ID: 7203570
    [No Abstract]   [Full Text] [Related]  

  • 18. An analysis of the factors allowing promotion (rather than inhibition) of tumour growth by Corynebacterium parvum.
    Bomford R
    Int J Cancer; 1977 May; 19(5):673-9. PubMed ID: 863546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A bladder tumor model response to immunotherapy.
    deKernion JB; Ramming KP; Fraser K
    Natl Cancer Inst Monogr; 1978 Dec; (49):333. PubMed ID: 748789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proceedings: Immunotherapy of Moloney sarcoma virus tumours in mice with Corynebacterium parvum.
    Hamilton DN; Bell PR
    Br J Surg; 1974 Apr; 61(4):321. PubMed ID: 4832648
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.